108 related articles for article (PubMed ID: 7047163)
21. Synthetic glycolipid adjuvants.
Behling UH; Campbell B; Chang CM; Rumpf C; Nowotny A
J Immunol; 1976 Sep; 117(3):847-51. PubMed ID: 60450
[TBL] [Abstract][Full Text] [Related]
22. The effect of epitope density on the in vitro immunogenicity of hapten-sensitized liposomal model membranes.
Tadakuma T; Yasuda T; Kinsky SC; Pierce CW
J Immunol; 1980 May; 124(5):2175-9. PubMed ID: 6154094
[No Abstract] [Full Text] [Related]
23. Importance of fatty acid substituents of chemically synthesized lipid A-subunit analogs in the expression of immunopharmacological activity.
Kumazawa Y; Nakatsuka M; Takimoto H; Furuya T; Nagumo T; Yamamoto A; Homma Y; Inada K; Yoshida M; Kiso M
Infect Immun; 1988 Jan; 56(1):149-55. PubMed ID: 3257202
[TBL] [Abstract][Full Text] [Related]
24. Immunogenicity of liposomal model membranes.
Kinsky SC
Ann N Y Acad Sci; 1978; 308():111-23. PubMed ID: 279284
[No Abstract] [Full Text] [Related]
25. Liposomes as vehicles for vaccines.
Alving CR; Banerji B; Shiba T; Kotani S; Clements JD; Richards RL
Prog Clin Biol Res; 1980; 47():339-55. PubMed ID: 7208512
[TBL] [Abstract][Full Text] [Related]
26. Mitogenic and polyclonal B cell activation activities of synthetic lipid A analogues.
Kumazawa Y; Matsuura M; Nakatsuru-Watanabe Y; Fukumoto M; Nishimura C; Homma JY; Inage M; Kusumoto S; Shiba T
Eur J Immunol; 1984 Feb; 14(2):109-14. PubMed ID: 6199209
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant effect of endotoxin; antibody response to sheep erythrocytes in mice after transfer of syngeneic lymphoid cells treated with bacterial lipopolysaccharide in vitro.
Nakano M; Uchiyama T; Saito K
J Immunol; 1973 Feb; 110(2):408-13. PubMed ID: 4567393
[No Abstract] [Full Text] [Related]
28. Effect of lipid A-associated protein and lipid A on the expression of lipopolysaccharide activity. I. Immunological activity.
Izui S; Morrison DC; Curry B; Dixon FJ
Immunology; 1980 Jul; 40(3):473-82. PubMed ID: 7000681
[TBL] [Abstract][Full Text] [Related]
29. Genetic control of in vivo sensitivity to lipopolysaccharide: evidence for codominant inheritance.
McGhee JR; Michalek SM; Moore RN; Mergenhagen SE; Rosenstreich DL
J Immunol; 1979 May; 122(5):2052-8. PubMed ID: 448116
[No Abstract] [Full Text] [Related]
30. The use of allogeneic T lymphocytes and bacterial lipopolysaccharide to induce immune responses to monovalent haptens in vitro.
Trenkner E
J Immunol; 1974 Sep; 113(3):918-24. PubMed ID: 4153527
[No Abstract] [Full Text] [Related]
31. Immunogenic properties of liposomal model membranes in mice.
Yasuda T; Dancey GF; Kinsky SC
J Immunol; 1977 Dec; 119(6):1863-7. PubMed ID: 334973
[TBL] [Abstract][Full Text] [Related]
32. The lipid A immunity system. I. Induction of heterophile antibodies by enterobacterial lipopolysaccharides and their lipid A component.
Rank WR; DiPauli R; Flügge-Rank U
Eur J Immunol; 1972 Dec; 2(6):517-22. PubMed ID: 4569996
[No Abstract] [Full Text] [Related]
33. Induction of splenic T cell proliferation by lipid A in mice immunized with sheep red blood cells.
Mita A; Ohta H; Mita T
J Immunol; 1982 Apr; 128(4):1709-11. PubMed ID: 7037954
[TBL] [Abstract][Full Text] [Related]
34. Differences of chemical structures of Pseudomonas aeruginosa lipopolysaccharide essential for adjuvanticity and antitumor and interferon-inducing activities.
Cho Y; Tanamoto K; Oh Y; Homma JY
FEBS Lett; 1979 Sep; 105(1):120-2. PubMed ID: 114416
[No Abstract] [Full Text] [Related]
35. Effect of lipid A incorporation on characterization of liposomal model membranes as thymus-independent type 1 or type 2 immunogens.
Tadakuma T; Yasuda T; Tamauchi H; Saito K; Tsumita T; Kinsky SC
J Immunol; 1982 Jan; 128(1):206-10. PubMed ID: 6976372
[TBL] [Abstract][Full Text] [Related]
36. Liposomes as immunological adjuvants in eliciting antibodies specific to the synthetic polypeptide poly(LTyr, LGlu)-poly(DLAla)--(LLys) with high frequency of site-associated idiotypic determinants.
Lifshitz R; Gitler C; Mozes E
Eur J Immunol; 1981 May; 11(5):398-404. PubMed ID: 7262180
[TBL] [Abstract][Full Text] [Related]
37. Characterization of immunogenic properties of haptenated liposomal model membranes in mice. I. Thymus independence of the antigen.
van Houte AJ; Snippe H; Willers JM
Immunology; 1979 Jun; 37(2):505-14. PubMed ID: 381183
[TBL] [Abstract][Full Text] [Related]
38. Studies on the adjuvant effect of Bordetella pertussis vaccine to sheep erythrocytes in the mouse. I. In vitro enhancement of antibody formation with normal spleen cells.
Murgo AJ; Athanassiades TJ
J Immunol; 1975 Oct; 115(4):928-31. PubMed ID: 170337
[TBL] [Abstract][Full Text] [Related]
39. Lipid A structures containing novel lipid moieties: synthesis and adjuvant properties.
Jiang ZH; Bach MV; Budzynski WA; Krantz MJ; Koganty RR; Longenecker BM
Bioorg Med Chem Lett; 2002 Aug; 12(16):2193-6. PubMed ID: 12127535
[TBL] [Abstract][Full Text] [Related]
40. Strain differences in the fine specificity of mouse anti-hapten antibodies.
Imanishi T; Mäkelä O
Eur J Immunol; 1973 Jun; 3(6):323-30. PubMed ID: 4586168
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
